Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 21 Jun 2023 for Deciphera Pharmaceuticals, Inc., €22k. Read the official filing
Filing timeline
BuySaleDaniel Lee Flynn
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Daniel Lee Flynn: trading record in brief
Daniel Lee Flynn (senior executive) discloses dealings in Deciphera Pharmaceuticals, Inc. to SEC (Form 4). We count 7 filings; the first trade dates from 15 December 2021 and the latest from 16 June 2023.
Sales make up the whole of the open-market record (4 sales, €98k). Other entries cover 3 share grants. 2023 to date brings no purchases and 2 sales.
On 21 June 2023 came the latest disclosure, an open-market sale for €22k in Deciphera Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Daniel Lee Flynn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
1,655 shares@ US$14.401820.0% of flowCommon StockSEC:0001209191-23-038753:0
16,488 shares0Common StockSEC:0001209191-23-010488:0
2,403 shares@ US$21.241343.4% of flowCommon StockSEC:0001209191-23-004001:0
1,768 shares@ US$10.7545.3% of flowCommon StockSEC:0001209191-22-038425:0
1,366 shares@ US$9.0511.1% of flowCommon StockSEC:0001209191-22-011360:0
20,500 shares0Common StockSEC:0001209191-22-004074:0
11,100 shares0Common StockSEC:0001209191-21-070227:0
7 of 7 declarations
